Ricardo Scheiber-Camoretti

University of Chicago

Papers

1

Total Citations

7

H-Index

1

About

Ricardo Scheiber-Camoretti’s research focuses on the intersection of cardiac surgery, inflammation, and biomarker discovery, with a particular emphasis on improving patient outcomes after coronary artery bypass grafting (CABG). His most cited work investigates the role of S100A12 and soluble receptor for advanced glycation endproducts (sRAGE) as predictive markers in post-surgical recovery. In a pivotal 2013 study, he demonstrated that elevated plasma levels of these inflammatory mediators are significantly associated with prolonged hospitalization following non-urgent CABG surgery. This finding offers clinicians a potential tool for early risk stratification and personalized postoperative care. With 7 citations, this work has contributed to a growing understanding of how the inflammatory response impacts recovery trajectories in cardiac patients. Scheiber-Camoretti’s contributions are particularly valuable for researchers and clinicians seeking to translate molecular markers into practical prognostic indicators, bridging the gap between bench research and bedside decision-making in cardiovascular surgery.

Research Focus

Key Achievements

1
H-Index
1
Papers
7
Total Citations
7
Avg Citations/Paper
🏆 Most Cited Paper
Elevated S100A12 and sRAGE are associated with increased length of hospitalization after non-urgent coronary artery bypass grafting surgery.
7 citations · 2013
📈 Most Prolific Year: 2013 (1 Papers)
🤝 Key Collaborators: 5
🏛 Institutions: University of Chicago

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago